X
KPIs and MIDs in Clinical Endpoint Adjudication: Why They Matter and How to Use Them

By Ethical 13 Nov, 2024

KPIs and MIDs in Clinical Endpoint Adjudication: Why They Matter and How to Use Them

In clinical endpoint adjudication, the ability to track performance and efficiency is crucial to the success of any trial. Key Performance Indicators (KPIs) provide the data needed to ensure that every stage of the process runs smoothly. By monitoring these metrics, clinical teams can identify potential challenges early and make informed decisions. In this blog post, we’ll explore the most essential KPIs and how they can help you achieve better outcomes in your adjudication process.

In the world of clinical trials, the adjudication process plays a vital role in ensuring that complex medical events are accurately evaluated. To effectively steer the process, clinical development professionals need clear metrics to monitor performance, efficiency, and quality. These metrics are often referred to as Key Performance Indicators (KPIs). With the right KPIs in place, clinical teams can streamline the adjudication process, address any bottlenecks, and maintain a high standard of decision-making throughout the trial.

What are KPIs in Endpoint Adjudication?

KPIs in endpoint adjudication measure various aspects of the process, from timing to quality control. These indicators offer insights into how well the adjudication process is progressing, highlight areas that may need intervention, and provide transparency on the efficiency of the team. By tracking KPIs, clinical development professionals can maintain oversight and ensure that the process remains on track, ultimately improving trial outcomes.

Frequently Used KPIs in Clinical Endpoint Adjudication

  1. Study Statistics: These statistics are essential for monitoring overall study progress, especially when it comes to the number of recorded events versus expected events. Metrics like the number of pending cases, new and closed events, and the distribution of events by type or status provide a real-time snapshot of the study’s health. For example:
    • Pending cases by time period help assess whether study coordinators or reviewers are keeping up with the expected pace.
    • New events and closed events by month allow the clinical team to track performance over time.
    • Events by status (e.g., “pending review,” “more data requested”) reveal where bottlenecks might be forming in the adjudication process.
  2. Site-monitoring: All sites don’t work equally well. Monitoring the workload, quality and speed for each individual site allows to identify outliers and act on time. For example:
    • Time-window for documents upload
    • Number of queries opened
  3. Reviewer-Specific Metrics: Reviewing pending events by reviewer and tracking discrepancies or disagreements among them can reveal whether any particular reviewer requires additional support or attention. For example, a reviewer with significantly more pending cases or a high rate of disagreements may need closer monitoring or additional training.
  4. Disagreements and Deviations: Monitoring disagreements by period or reviewer helps to detect trends that may require a deeper look. If a particular reviewer consistently has more disagreements, or if disagreement rates rise during a specific phase, it might signal a need for process adjustments or further discussions within the adjudication committee.

Time-Based KPIs

Time is a crucial factor in endpoint adjudication, as delays at any stage can hinder the entire trial’s progress. Common time-based KPIs include:

  • Time from event creation to submission for review: This measures how efficiently the initial data is handled.
  • Time from submission to closing: This KPI captures how long it takes to reach a decision once an event is submitted.
  • Time for query resolution: Whether resolving a minor or major deviation or clearing up missing data, this metric highlights how quickly issues are being addressed.

Additionally, monitoring the time for translation, time for coordinators to review events, and time for sites to upload or respond to queries all help the clinical team keep the adjudication process moving efficiently.

Quality Control Measures in Adjudication

Quality control is an integral part of any clinical trial process, and endpoint adjudication is no exception. KPIs tied to quality control measure the consistency and accuracy of the adjudication process. Some key quality control metrics include:

  • Number of discrepancies by event type: This metric helps identify patterns that could indicate systematic issues with certain types of events.
  • Major deviations reported per quality control round: Keeping track of deviations ensures that any significant issues are caught and addressed before they affect the study’s integrity.
  • Events closed with or without discrepancies: This provides an indication of how well the adjudication process is being managed from a quality perspective.

The goal of quality control KPIs is to maintain high standards in the adjudication process. If discrepancies or deviations exceed predefined thresholds, corrective actions must be taken to preserve the study’s quality.

The Importance of Regular Monitoring

Monitoring KPIs from the beginning of the adjudication process is essential for maintaining smooth operations and minimizing delays. These metrics provide early warning signs of issues, allowing the clinical team to intervene before they escalate. For instance, if a reviewer is consistently slow to close events, or if there’s a spike in disagreements during a particular phase, the clinical team can take swift action to correct the problem, such as providing additional training or clarifying study protocols.

Moreover, closely watching KPIs ensures that the adjudication process remains aligned with the endpoint adjudication charter and platform settings, helping prevent misunderstandings and reducing the risk of deviations. With KPIs, the clinical team can effectively steer the process, optimize performance, and maintain transparency throughout the trial.

Minimal Important Differences (MIDs) and action plans

While monitoring KPIs may seem a potent way of managing a complex process such as clinical endpoint adjudication, it requires defining upfront which deviations constitute minimal important differences from target and what actions will be taken should a particular KPI reach these inflexion points. As described above, for example, a reviewer with significantly more pending cases may need re-training. Definig upfront what is significant in this case (in term or number, percentage, deviation or any other chosen parameter) will allow the coordinator to trigger a training invitation in this example.

A Reliable Solution for KPI Management: eAdjudication® by Ethical

Managing all these KPIs can be a complex task without the right tools in place. Ethical's eAdjudication® software simplifies this process by providing a comprehensive set of KPIs tailored to the specific needs of clinical endpoint adjudication. With real-time tracking of both time-based and quality control KPIs, the platform ensures that clinical teams have the insights they need to stay on track and make informed decisions.

If you’re looking for a reliable solution to streamline your adjudication process and improve oversight, reach out to Ethical today to learn more about how eAdjudication® can support your clinical trials. Please use the form below, we’ll be in touch soon.

Tags

Download Ethical eAdjudication for Endpoint Adjudication Dossier

eAdjudication®
Solution Description

DOWNLOAD NOW

Book a call to discover the eAdjudication® solution

Please fill out this form and we’ll be in touch as soon as we can.